GE Healthcare will collaborate with Wego Pharmaceutical in China for local production and supply of GE Healthcare’s Fortem single-use consumables.
GE Healthcare will manufacture single-use consumables for bioprocessing in Weihai, China, in collaboration with Wego Pharmaceutical, GE Healthcare announced in a Nov. 7, 2018 press release. This collaboration will decrease product delivery times for Chinese biopharmaceutical companies, enhance customer support locally, and increase access to a wide range of standard and custom single-use products.
The first single-use consumables produced at Wego’s manufacturing facility will be available in 2018, with continued offerings released throughout 2019. All products will be manufactured using Fortem, GE Healthcare’s single-use platform film, which simplifies customer validation and approval processes by incorporating GE’s full range of bioprocessing systems.
“We are excited to play a critical role within the Chinese biopharma industry by ensuring efficient lead times and security of supply, which ultimately helps the local manufacturers to serve patients faster. China continues to lead in the adoption of innovative single-use biomanufacturing solutions, including GE Healthcare’s end-to-end biomanufacturing solutions KUBio and FlexFactory,” said Olivier Loeillot, general manager, BioProcess, GE Healthcare Life Sciences, in a company press release.
Source: GE Healthcare
Thermo Fisher Opens Advanced Therapies Collaboration Center in California
April 18th 2025The 6000-square-foot facility will provide cell therapy developers the support they need to transition to CGMP manufacturing, and an expanded footprint of the new center is expected to open in Philadelphia later in 2025.